ESC 365 - The effect of empagliflozin on ketone bodies in patients with heart failure with reduced ejection fraction (Empire HF)

ESC Professional Premium Access

The effect of empagliflozin on ketone bodies in patients with heart failure with reduced ejection fraction (Empire HF)

Session: New pathophysiological insights of heart failure

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor M. Omar (Odense, DK)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Massar Omar

Odense University Hospital, Odense (Denmark)

0 follower

5 more presentations in this session

Myocardial DNA damage combined with genotype predicts heart failure outcome in various underlying diseases

Speaker: Doctor Z. Dai (Tokyo, JP)

Interleukin 17A-correlated myocarditis in patients with psoriasis: cardiac recovery following secukinumab administration

Speaker: Doctor A. Frustaci (Rome, IT)

Pathophysiological role of epicardial adipose tissue and its phenotypes in patients with diabetes and cardiovascular comorbidities.

Speaker: Doctor S. Kotha (Leeds, GB)

The right ventricle is not spared by the cardiotoxic effects of chemotherapy for breast cancer. Results of SAFE trial.

Speaker: Doctor M. Del Bene (Florence, IT)

Transcriptional regulation of macrophage inflammation in the heart failure with preserved ejection fraction: a translational study

Speaker: Doctor E. Gorica (Zurich, CH)

Access the full session

New pathophysiological insights of heart failure

Speakers: Doctor M. Omar, Doctor Z. Dai, Doctor A. Frustaci, Doctor S. Kotha, Doctor M. Del Bene...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources